PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 12, 20260 citations

Integrated Plasma Proteomics and Functional Analyses Reveal Hepatic CDHR2 as a Potential Therapeutic Target in MASLD.

View Full Paper
YSYan ShiQHQi HuangYLYingning Liu

Key Points

  • The study aims to investigate CDHR2's role in the development and progression of MASLD.
  • Utilized integrated plasma proteomics
  • Conducted functional analyses
  • Focused on hepatic tissues and biomarkers
  • Identified CDHR2 as a novel regulator of MASLD
  • Highlighted the potential of CDHR2 as a therapeutic target for treatment

Abstract

These findings identify CDHR2 as a novel regulator of MASLD development and progression, and highlight it as a potential therapeutic target.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Shi et al. (2026) studied this question.

synapsesocial.com/papers/69b25b5496eeacc4fcec9ffchttps://doi.org/10.1111/dom.70623
Ask AI
Helpful
Bookmark
Share
View Full Paper